His primary scientific interests are in Immunology, T cell, Cell biology, CD28 and Cytotoxic T cell. His Immunology research incorporates elements of Receptor and Cancer research. His T cell research includes themes of Molecular biology, CD3 and CD40.
His biological study spans a wide range of topics, including Immunoglobulin light chain, Antibody and Monoclonal antibody. In his study, Phosphorylation is strongly linked to T-cell receptor, which falls under the umbrella field of Cell biology. His Cytotoxic T cell research integrates issues from Mutation, CD8, Viral replication and Virology.
His primary areas of investigation include Immunology, Immune system, T cell, Cell biology and Cancer research. In his research, Stem cell is intimately related to Transplantation, which falls under the overarching field of Immunology. His work in Immune system addresses subjects such as Internal medicine, which are connected to disciplines such as Surgery.
The concepts of his T cell study are interwoven with issues in Molecular biology and Cytotoxic T cell, CD40. His study looks at the relationship between Cell biology and topics such as Receptor, which overlap with Cell. His Cancer research research is multidisciplinary, incorporating perspectives in Immune checkpoint, Tumor microenvironment, Cancer, Cell culture and Flow cytometry.
Daniel Olive focuses on Cancer research, Immune system, Immunotherapy, Cancer and Cytotoxic T cell. His work deals with themes such as Immune checkpoint, Cell, Cancer immunotherapy and Antibody, Monoclonal antibody, which intersect with Cancer research. Immune checkpoint is a subfield of Immunology that he investigates.
His work carried out in the field of Immune system brings together such families of science as Internal medicine, Melanoma and Oncology. The Immunotherapy study combines topics in areas such as Cancer cell, Lung cancer and Myeloid leukemia. Daniel Olive focuses mostly in the field of Cytotoxic T cell, narrowing it down to topics relating to Cytokine and, in certain cases, Pharmacology.
His primary scientific interests are in Cancer research, Immune system, Cancer, Cytotoxic T cell and Immunotherapy. His studies deal with areas such as Internal medicine and Oncology as well as Immune system. His Cancer study incorporates themes from Blockade, Antibody and Lung cancer.
His Cytotoxic T cell research is multidisciplinary, incorporating perspectives in Tumor microenvironment, CD8, Germinal center and Interleukin 4. His research investigates the connection between Immunotherapy and topics such as Myeloid leukemia that intersect with problems in Multiple myeloma, Leukemia, Pomalidomide and Lenalidomide. His Immune checkpoint study contributes to a more complete understanding of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert;Isabelle Treilleux;Nathalie Bendriss-Vermare;Thomas Bachelot.
Cancer Research (2009)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.
Régis T. Costello;Simona Sivori;Emanuela Marcenaro;Marina Lafage-Pochitaloff.
PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cécile Badoual;Stéphane Hans;Nathalie Merillon;Cordélia Van Ryswick.
Cancer Research (2013)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier;Aude Sylvain;Marie-Laure Thibult;Gilles Houvenaeghel.
Journal of Clinical Investigation (2011)
Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Françoise Pagès;Marguerite Ragueneau;Robert Rottapel;Robert Rottapel;Alemseged Truneh.
PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat;Sylvaine Just-Landi;Françoise Mallet;Christine Arnoulet.
CpG methylation controls reactivation of HIV from latency.
Jana Blazkova;Katerina Trejbalova;Katerina Trejbalova;Françoise Gondois-Rey;Philippe Halfon.
PLOS Pathogens (2009)
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Régis T. Costello;Françoise Mallet;Béatrice Gaugler;Danielle Sainty.
Cancer Research (2000)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly;Christelle Harly;Christelle Harly;Yves Guillaume;Steven Nedellec;Steven Nedellec;Steven Nedellec;Cassie-Marie Peigné;Cassie-Marie Peigné;Cassie-Marie Peigné.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: